An Agitated Patient With COVID-19 Infection and Early-onset Alzheimer Disease.
Alzheimer Dis Assoc Disord
; 36(1): 83-84, 2022.
Article
in English
| MEDLINE | ID: covidwho-1223417
ABSTRACT
Encephalopathy, delirium, and agitation are documented symptoms of coronavirus disease (COVID-19) infection, but research into the management of agitation in the setting of COVID-19 and pre-existing neuropsychiatric disease is ongoing. We present a 55-year-old male patient with early-onset Alzheimer disease and deteriorating mental and functional status who presented to our institution with agitation and persistent COVID-19 positivity on polymerase chain reaction testing. His agitation was improved through pharmacologic optimization including the avoidance of benzodiazepines and initiation of clonidine and prazosin, which temporally coincided with the resolution of his nearly 2-month long COVID-19 positivity.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Alzheimer Disease
/
COVID-19
Type of study:
Case report
/
Diagnostic study
Topics:
Long Covid
Limits:
Humans
/
Male
/
Middle aged
Language:
English
Journal:
Alzheimer Dis Assoc Disord
Journal subject:
Neurology
/
Psychiatry
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS